Guggenheim Initiates Coverage On Nanobiotix with Buy Rating, Announces Price Target of $12
Portfolio Pulse from Benzinga Newsdesk
Guggenheim has initiated coverage on Nanobiotix (NASDAQ:NBTX) with a Buy rating and set a price target of $12.
August 28, 2024 | 11:27 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guggenheim has initiated coverage on Nanobiotix with a Buy rating and a price target of $12, indicating positive expectations for the stock.
The initiation of coverage with a Buy rating and a specific price target by a reputable firm like Guggenheim is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100